Predicting therapy response by analysis of metastasis founder cells: emerging perspectives for personalized tumor therapy

Circulating tumor and disseminated cancer cells can be detected after surgical removal of the primary tumor in non-metastatic patients. Despite being considered the prime targets of adjuvant therap...